Co-Producer
|
|
| AUGUST
28, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jason Cole, CEO and Board Member, Zag Bio,
Inc. |
In
this week’s CEO Q&A, Cole, who lives
with type 1 diabetes himself, discusses
the science behind Zag’s thymus-targeted
platform, what differentiates its approach
from other immune-tolerance strategies in
development, and his outlook for turning
immune tolerance from long-standing
scientific aspiration into real therapies
for patients. More
|
|
|
|
|
Join
us September 30 – October 1 for
LSPA’s largest partnering event of
the year. Connect with the life
sciences ecosystem throughout the
Commonwealth and beyond, get the
latest information through timely
panel discussions and learn about
the newest innovations shaping the
industry.
|
|
Learn More
→ |
|
|
- Aprea Therapeutics: Expansion of
Intellectual Property Portfolio for
Precision Oncology Programs More
More
- Penn Medicine: Researchers Uncover How a
Leading Class of Heart Failure Drug Powers
the Heart More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- BMS Splashes Out $173M to Build 2nd
Radiopharmaceutical Plant in Indiana More
- LSN: Hot Investor Mandate (Updated 8/25) More
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- Big4Bio CEO Weekly Q&A: Jason
Cole, CEO and Board Member, Zag Bio, Inc. More
- BioPharmGuy News: 2nd Place Finish, Sugar
Problems, Ghost Roast, Mummy Issues, Fruit
Buds More
- Biotech & Pharma Updates | August 27,
2026 More
- Future of AstraZeneca's Gene Silencer in
Heart Disease Uncertain After Trial Failure More*
- More on Amgen, AZ's Tezspire Landing
Phase 3 Eosinophilic Esophagitis Win,
Turning Up Heat on Dupixent More
More
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- ICYMI: ANI Pharmaceuticals Appoints Henry
Gosebruch to Board of Directors More
- ICYMI: Former Spark Executives Steering Nava
Therapeutics to 'Extraordinary Progress' More*
- ICYMI: SJU Podcast: Path to
Commercialization in Healthcare -
PatientPoint's Jane Moreland Wojcik is
Interviewed by Carly Poff & Jon Evoy Podcast
- OPPORTUNITY: Head of Computational Method
Development, Boston More
- OPPORTUNITY: Chief Operating Officer, Remote
More
- OPPORTUNITY: Computational Scientist, New
York More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences -
When it Works and Why More
- Slone Partners: Places Farhad Ghavami as
Chief Executive Officer at SeqCenter More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Philadelphia Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Philadelphia,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
